No material insider buying or selling is occurring; the sole sale is negligible relative to market cap. Routine equity compensation and exercises dominate, no actionable signal for traders.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 16 $86.77entry
- T+1 · 8mo ago +1.71%α +1.43% · $88.25
- T+5 · 8mo ago −2.34%α −0.30% · $84.74
- T+20 · 7mo ago −0.56%α −4.34% · $86.29
- T+60 · 5mo ago +43.93%α +33.44% · $124.89
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A recent insider trading cluster at Guardant Health shows multiple non-cash derivative exercises and share awards, with one small open-market sale of $30,655 by a director. The majority of transactions are routine equity events, not indicative of material sentiment.
Key Financial Metrics
Key Facts
- Two Co-CEOs (Eltoukhy Helmy and Talasaz AmirAli) were each granted 11,268 shares at $0, non-cash, likely part of regular compensation.
- Directors Mignone Roberto and Hidalgo Medina Manuel each exercised derivative positions twice (264 and 232 shares respectively), non-cash transactions.
- Director Tariq Musa sold 348 shares in the open market for $30,655.32 at $88.09 per share.
- Total open-market selling value: $30,655, less than 0.001% of $11.2B market cap.
- All other trades are non-cash (codes A, M) and carry no direct economic signal.
Financial Impact
$30,655 in net open-market selling; $0 from non-cash transactions
Risk Factors
- Minimal risk from insider activity; the small sale does not suggest material concern.
- Non-cash transactions could lead to slight future dilution, but grants are within normal range.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-GH-1774297198242 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers